The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Regenerative Medicine Market Research Report 2024

Global Regenerative Medicine Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1419073

No of Pages : 104

Ask Your Query

Synopsis

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.

Regenerative medicine is defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function and has been called the "next evolution of medical treatments" and “the vanguard of 21st century healthcare” by the U.S. Department of Health and Human Services.

The global Regenerative Medicine market was valued at US$ 33370 million in 2023 and is anticipated to reach US$ 115660 million by 2030, witnessing a CAGR of 19.2% during the forecast period 2024-2030.

Global Regenerative Medicine key players include J & J (DePuy Synthes), Medtronic, Allergan(Acelity), Zimmer Biomet, etc. Global top four manufacturers hold a share about 10%.

North America is the largest market, with a share about 25%, followed by Europe, and Asia Pacific, both have a share over 40 percent.

In terms of product, Tissue Engineering is the largest segment, with a share over 40%. And in terms of application, the largest application is Dermatology, followed by Cardiovascular, CNS, Orthopedic, etc.

This report aims to provide a comprehensive presentation of the global market for Regenerative Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Regenerative Medicine.

Report Scope

The Regenerative Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Regenerative Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Regenerative Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • J & J (DePuy Synthes)
  • Medtronic
  • Zimmer Biomet
  • Stryker
  • Allergan(Acelity)
  • MiMedx Group
  • Organogenesis
  • Fujifilm Cellular Dynamics
  • Osiris Therapeutics
  • Vcanbio
  • CCBC
  • Cytori
  • Celgene
  • Vericel Corporation
  • Guanhao Biotech
  • Mesoblast
  • AMAG Pharmaceuticals (CBR)
  • ViaCord
  • CordLife
  • Integra LifeSciences
  • Nuvasive
  • Cook Biotech
  • Japan Tissue Engineering

Segment by Type

  • Cell Therapy
  • Tissue Engineering
  • Biomaterial
  • Other

Segment by Application

  • Dermatology
  • Cardiovascular
  • CNS
  • Orthopedic
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Regenerative Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regenerative Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Biomaterial
1.2.5 Other
1.3 Market by Application
1.3.1 Global Regenerative Medicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Dermatology
1.3.3 Cardiovascular
1.3.4 CNS
1.3.5 Orthopedic
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Regenerative Medicine Market Perspective (2019-2030)
2.2 Regenerative Medicine Growth Trends by Region
2.2.1 Global Regenerative Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Regenerative Medicine Historic Market Size by Region (2019-2024)
2.2.3 Regenerative Medicine Forecasted Market Size by Region (2025-2030)
2.3 Regenerative Medicine Market Dynamics
2.3.1 Regenerative Medicine Industry Trends
2.3.2 Regenerative Medicine Market Drivers
2.3.3 Regenerative Medicine Market Challenges
2.3.4 Regenerative Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Regenerative Medicine Players by Revenue
3.1.1 Global Top Regenerative Medicine Players by Revenue (2019-2024)
3.1.2 Global Regenerative Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Regenerative Medicine Revenue
3.4 Global Regenerative Medicine Market Concentration Ratio
3.4.1 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regenerative Medicine Revenue in 2023
3.5 Regenerative Medicine Key Players Head office and Area Served
3.6 Key Players Regenerative Medicine Product Solution and Service
3.7 Date of Enter into Regenerative Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Regenerative Medicine Breakdown Data by Type
4.1 Global Regenerative Medicine Historic Market Size by Type (2019-2024)
4.2 Global Regenerative Medicine Forecasted Market Size by Type (2025-2030)
5 Regenerative Medicine Breakdown Data by Application
5.1 Global Regenerative Medicine Historic Market Size by Application (2019-2024)
5.2 Global Regenerative Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Regenerative Medicine Market Size (2019-2030)
6.2 North America Regenerative Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Regenerative Medicine Market Size by Country (2019-2024)
6.4 North America Regenerative Medicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Regenerative Medicine Market Size (2019-2030)
7.2 Europe Regenerative Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Regenerative Medicine Market Size by Country (2019-2024)
7.4 Europe Regenerative Medicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Regenerative Medicine Market Size (2019-2030)
8.2 Asia-Pacific Regenerative Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Regenerative Medicine Market Size by Region (2019-2024)
8.4 Asia-Pacific Regenerative Medicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Regenerative Medicine Market Size (2019-2030)
9.2 Latin America Regenerative Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Regenerative Medicine Market Size by Country (2019-2024)
9.4 Latin America Regenerative Medicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Regenerative Medicine Market Size (2019-2030)
10.2 Middle East & Africa Regenerative Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Regenerative Medicine Market Size by Country (2019-2024)
10.4 Middle East & Africa Regenerative Medicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 J & J (DePuy Synthes)
11.1.1 J & J (DePuy Synthes) Company Detail
11.1.2 J & J (DePuy Synthes) Business Overview
11.1.3 J & J (DePuy Synthes) Regenerative Medicine Introduction
11.1.4 J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2019-2024)
11.1.5 J & J (DePuy Synthes) Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Detail
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Regenerative Medicine Introduction
11.2.4 Medtronic Revenue in Regenerative Medicine Business (2019-2024)
11.2.5 Medtronic Recent Development
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Detail
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Regenerative Medicine Introduction
11.3.4 Zimmer Biomet Revenue in Regenerative Medicine Business (2019-2024)
11.3.5 Zimmer Biomet Recent Development
11.4 Stryker
11.4.1 Stryker Company Detail
11.4.2 Stryker Business Overview
11.4.3 Stryker Regenerative Medicine Introduction
11.4.4 Stryker Revenue in Regenerative Medicine Business (2019-2024)
11.4.5 Stryker Recent Development
11.5 Allergan(Acelity)
11.5.1 Allergan(Acelity) Company Detail
11.5.2 Allergan(Acelity) Business Overview
11.5.3 Allergan(Acelity) Regenerative Medicine Introduction
11.5.4 Allergan(Acelity) Revenue in Regenerative Medicine Business (2019-2024)
11.5.5 Allergan(Acelity) Recent Development
11.6 MiMedx Group
11.6.1 MiMedx Group Company Detail
11.6.2 MiMedx Group Business Overview
11.6.3 MiMedx Group Regenerative Medicine Introduction
11.6.4 MiMedx Group Revenue in Regenerative Medicine Business (2019-2024)
11.6.5 MiMedx Group Recent Development
11.7 Organogenesis
11.7.1 Organogenesis Company Detail
11.7.2 Organogenesis Business Overview
11.7.3 Organogenesis Regenerative Medicine Introduction
11.7.4 Organogenesis Revenue in Regenerative Medicine Business (2019-2024)
11.7.5 Organogenesis Recent Development
11.8 Fujifilm Cellular Dynamics
11.8.1 Fujifilm Cellular Dynamics Company Detail
11.8.2 Fujifilm Cellular Dynamics Business Overview
11.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Introduction
11.8.4 Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2019-2024)
11.8.5 Fujifilm Cellular Dynamics Recent Development
11.9 Osiris Therapeutics
11.9.1 Osiris Therapeutics Company Detail
11.9.2 Osiris Therapeutics Business Overview
11.9.3 Osiris Therapeutics Regenerative Medicine Introduction
11.9.4 Osiris Therapeutics Revenue in Regenerative Medicine Business (2019-2024)
11.9.5 Osiris Therapeutics Recent Development
11.10 Vcanbio
11.10.1 Vcanbio Company Detail
11.10.2 Vcanbio Business Overview
11.10.3 Vcanbio Regenerative Medicine Introduction
11.10.4 Vcanbio Revenue in Regenerative Medicine Business (2019-2024)
11.10.5 Vcanbio Recent Development
11.11 CCBC
11.11.1 CCBC Company Detail
11.11.2 CCBC Business Overview
11.11.3 CCBC Regenerative Medicine Introduction
11.11.4 CCBC Revenue in Regenerative Medicine Business (2019-2024)
11.11.5 CCBC Recent Development
11.12 Cytori
11.12.1 Cytori Company Detail
11.12.2 Cytori Business Overview
11.12.3 Cytori Regenerative Medicine Introduction
11.12.4 Cytori Revenue in Regenerative Medicine Business (2019-2024)
11.12.5 Cytori Recent Development
11.13 Celgene
11.13.1 Celgene Company Detail
11.13.2 Celgene Business Overview
11.13.3 Celgene Regenerative Medicine Introduction
11.13.4 Celgene Revenue in Regenerative Medicine Business (2019-2024)
11.13.5 Celgene Recent Development
11.14 Vericel Corporation
11.14.1 Vericel Corporation Company Detail
11.14.2 Vericel Corporation Business Overview
11.14.3 Vericel Corporation Regenerative Medicine Introduction
11.14.4 Vericel Corporation Revenue in Regenerative Medicine Business (2019-2024)
11.14.5 Vericel Corporation Recent Development
11.15 Guanhao Biotech
11.15.1 Guanhao Biotech Company Detail
11.15.2 Guanhao Biotech Business Overview
11.15.3 Guanhao Biotech Regenerative Medicine Introduction
11.15.4 Guanhao Biotech Revenue in Regenerative Medicine Business (2019-2024)
11.15.5 Guanhao Biotech Recent Development
11.16 Mesoblast
11.16.1 Mesoblast Company Detail
11.16.2 Mesoblast Business Overview
11.16.3 Mesoblast Regenerative Medicine Introduction
11.16.4 Mesoblast Revenue in Regenerative Medicine Business (2019-2024)
11.16.5 Mesoblast Recent Development
11.17 AMAG Pharmaceuticals (CBR)
11.17.1 AMAG Pharmaceuticals (CBR) Company Detail
11.17.2 AMAG Pharmaceuticals (CBR) Business Overview
11.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Introduction
11.17.4 AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2019-2024)
11.17.5 AMAG Pharmaceuticals (CBR) Recent Development
11.18 ViaCord
11.18.1 ViaCord Company Detail
11.18.2 ViaCord Business Overview
11.18.3 ViaCord Regenerative Medicine Introduction
11.18.4 ViaCord Revenue in Regenerative Medicine Business (2019-2024)
11.18.5 ViaCord Recent Development
11.19 CordLife
11.19.1 CordLife Company Detail
11.19.2 CordLife Business Overview
11.19.3 CordLife Regenerative Medicine Introduction
11.19.4 CordLife Revenue in Regenerative Medicine Business (2019-2024)
11.19.5 CordLife Recent Development
11.20 Integra LifeSciences
11.20.1 Integra LifeSciences Company Detail
11.20.2 Integra LifeSciences Business Overview
11.20.3 Integra LifeSciences Regenerative Medicine Introduction
11.20.4 Integra LifeSciences Revenue in Regenerative Medicine Business (2019-2024)
11.20.5 Integra LifeSciences Recent Development
11.21 Nuvasive
11.21.1 Nuvasive Company Detail
11.21.2 Nuvasive Business Overview
11.21.3 Nuvasive Regenerative Medicine Introduction
11.21.4 Nuvasive Revenue in Regenerative Medicine Business (2019-2024)
11.21.5 Nuvasive Recent Development
11.22 Cook Biotech
11.22.1 Cook Biotech Company Detail
11.22.2 Cook Biotech Business Overview
11.22.3 Cook Biotech Regenerative Medicine Introduction
11.22.4 Cook Biotech Revenue in Regenerative Medicine Business (2019-2024)
11.22.5 Cook Biotech Recent Development
11.23 Japan Tissue Engineering
11.23.1 Japan Tissue Engineering Company Detail
11.23.2 Japan Tissue Engineering Business Overview
11.23.3 Japan Tissue Engineering Regenerative Medicine Introduction
11.23.4 Japan Tissue Engineering Revenue in Regenerative Medicine Business (2019-2024)
11.23.5 Japan Tissue Engineering Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock